Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Ovarian Neoplasms

  Free Subscription


Articles published in Eur J Obstet Gynecol Reprod Biol

Retrieve available abstracts of 64 articles:
HTML format



Single Articles


    March 2024
  1. RODOLAKIS I, Liontos M, Pergialiotis V, Haidopoulos D, et al
    Chemotherapy response score as a predictor of survival in ovarian cancer patients.
    Eur J Obstet Gynecol Reprod Biol. 2024;296:233-238.
    PubMed     Abstract available


  2. DABI Y, Rockall A, Razakamanantsoa L, Guerra A, et al
    O-RADS MRI scoring system has the potential to reduce the frequency of avoidable adnexal surgery.
    Eur J Obstet Gynecol Reprod Biol. 2024;294:135-142.
    PubMed     Abstract available


  3. MALIK N, Sahu B
    Counselling and management of women with genetic predisposition to gynaecological cancers.
    Eur J Obstet Gynecol Reprod Biol. 2024;294:44-48.
    PubMed     Abstract available


    February 2024
  4. BRAUN C, Grunig H, Peikert J, Strobel K, et al
    Do PET-positive supradiaphragmatic lymph nodes predict overall survival or the success of primary surgery in patients with advanced ovarian cancer?
    Eur J Obstet Gynecol Reprod Biol. 2024;296:13-19.
    PubMed     Abstract available


  5. SHIBAHARA M, Kurita T, Harada H, Tsuda Y, et al
    Therapeutic management of uterine tumours resembling ovarian sex cord tumours including a focus on fertility: A systematic review.
    Eur J Obstet Gynecol Reprod Biol. 2024;295:1-7.
    PubMed     Abstract available


    January 2024
  6. KATSANEVAKIS E, Addo-Yobo W, Bharathan B, Loona A, et al
    Is routine gastrointestinal endoscopy required in every woman with mucinous ovarian cancer? An analysis of survival rates and metastatic tumours in a cancer centre.
    Eur J Obstet Gynecol Reprod Biol. 2024;294:105-110.
    PubMed     Abstract available


  7. NIE X, Xu T, Zhang L, Cheng W, et al
    The Gustave Roussy immune score as a novel scoring system for predicting platinum resistance in advanced high-grade serous ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2024;294:97-104.
    PubMed     Abstract available


  8. PETIOT F, Descargues P, Devouassoux-Shisheboran M, You B, et al
    Retrospective analysis of uterine involvement in low grade serous ovarian carcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2024;294:191-197.
    PubMed     Abstract available


    November 2023
  9. LIBERIS A, Kyziridis D, Kalakonas A, Tentes AA, et al
    Cytoreductive surgery and perioperative intraperitoneal chemotherapy in recurrent ovarian cancer: 18 years of experience.
    Eur J Obstet Gynecol Reprod Biol. 2023;292:102-106.
    PubMed     Abstract available


  10. LUIS ALCAZAR J, Ramon Perez-Vidal J, Tameish S, Chacon E, et al
    Ultrasound for assessing tumor spread in ovarian cancer. A systematic review of the literature and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2023;292:194-200.
    PubMed     Abstract available


  11. SHARON A, Aiob A, Kais M, Apel-Sarid L, et al
    Detection and dissection of sentinel nodes in endometrial endometrioid cancer with indocyanine green using PinPoint laparoscopy: Analysis of the learning curve.
    Eur J Obstet Gynecol Reprod Biol. 2023;292:91-96.
    PubMed     Abstract available


    September 2023
  12. LEMS E, Leemans JC, Lok CAR, Bongers MY, et al
    Current uptake and barriers to wider use of the International Ovarian Tumor Analysis (IOTA) models in Dutch gynaecological practice.
    Eur J Obstet Gynecol Reprod Biol. 2023;291:240-246.
    PubMed     Abstract available


    July 2023
  13. PENG Y, Ur Rehman Aziz A, Wang Y, Li Q, et al
    Ovarian steroid cell tumour, not otherwise specified: A case report.
    Eur J Obstet Gynecol Reprod Biol. 2023 Jul 28:S0301-2115(23)00300.
    PubMed    


    April 2023
  14. TZANIS AA, Antoniou SA, Zacharoulis D, Ntafopoulos K, et al
    The role of systematic pelvic and para-aortic lymphadenectomy in the management of patients with advanced epithelial ovarian, tubal, and peritoneal cancer: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2023;285:198-203.
    PubMed     Abstract available


    March 2023
  15. MATSUO K, Rau AR, Machida H, Roman LD, et al
    Intraoperative rupture and chemotherapy use in stage I ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2023 Mar 20:S0301-2115(23)00105.
    PubMed    


    January 2023
  16. RALSER DJ, Condic M, Otten LA, Koensgen D, et al
    Evolving treatment landscape of advanced endometrial cancer - A current perspective from a German tertiary referral center for gynecological oncology.
    Eur J Obstet Gynecol Reprod Biol. 2023;282:61-63.
    PubMed    


    November 2022
  17. VALENTI G, Sopracordevole F, Chiofalo B, Forte S, et al
    Parenchymal liver metastasis in advanced ovarian cancer: Can bowel involvement influence the frequency and the related mortality rate?
    Eur J Obstet Gynecol Reprod Biol. 2022;280:48-53.
    PubMed     Abstract available


  18. YIN J, Li Y, Wang H, Wang W, et al
    Clinical outcomes of levonorgestrel-releasing intrauterine device present during controlled ovarian stimulation in patients with early stage endometrioid adenocarcinoma and atypical endometrial hyperplasia after fertility-sparing treatments: 10-year e
    Eur J Obstet Gynecol Reprod Biol. 2022;280:83-88.
    PubMed     Abstract available


  19. VAN TRAPPEN P, de Cuypere E, Claes N
    Robotic surgery in early and advanced ovarian cancer: Case selection for surgical staging and interval debulking surgery.
    Eur J Obstet Gynecol Reprod Biol. 2022;280:7-11.
    PubMed     Abstract available


    October 2022
  20. HUBER D, Fournier I, Christodoulou M, Seidler S, et al
    Stapled diaphragm resection: A new approach to diaphragmatic cytoreductive surgery for advanced-stage ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2022;279:88-93.
    PubMed     Abstract available


    September 2022
  21. MATAN LS, Perri T, Kogan L, Brandt B, et al
    Ovarian cancer risk management in BRCA-mutation carriers: A comparison of six international and national guidelines.
    Eur J Obstet Gynecol Reprod Biol. 2022;278:166-171.
    PubMed     Abstract available


  22. RODRIGUES TEIXEIRA F, Vertematti de Castro V, Chaves Faloppa C, Mantoan H, et al
    Impact of lymph node staging in presumed early-stage ovarian carcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2022;278:6-10.
    PubMed     Abstract available


    June 2022
  23. ROSATI A, Fedele C, Fagotti A, Lafuenti L, et al
    Needleoscopic-assisted risk-reducing bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers: Peri-operative outcomes and psychological impact.
    Eur J Obstet Gynecol Reprod Biol. 2022;273:1-6.
    PubMed     Abstract available


    March 2022
  24. ASSAF W, Andraous M, Lavie O, Segev Y, et al
    Attitudes of Israeli gynecologists towards risk reduction salpingo-oophorectomy at hysterectomy for benign conditions and the use of hormonal therapy.
    Eur J Obstet Gynecol Reprod Biol. 2022;272:48-54.
    PubMed     Abstract available


    February 2022
  25. GRAHAM R, MacDonald ND, Lockley M, Miller R, et al
    Surgical management and outcomes for stage 1 malignant ovarian germ cell tumours: A UK multicentre retrospective cohort study.
    Eur J Obstet Gynecol Reprod Biol. 2022;271:138-144.
    PubMed     Abstract available


    December 2021
  26. SOBICZEWSKI P, Piatek S, Michalski W, Kupryjanczyk J, et al
    Obstetric outcomes after conservative management of ovarian borderline tumors in women of reproductive age: A single center experience.
    Eur J Obstet Gynecol Reprod Biol. 2021;269:126-131.
    PubMed     Abstract available


  27. VALENTI G, Vitagliano A, Morotti M, Giorda G, et al
    Risks factors for anastomotic leakage in advanced ovarian cancer: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2021;269:3-15.
    PubMed     Abstract available


    November 2021
  28. WANG M, Liu K
    Advances in fertility preserving surgery for borderline ovarian tumors.
    Eur J Obstet Gynecol Reprod Biol. 2021;270:206-211.
    PubMed     Abstract available


  29. SHIGEYAMA M, Yoshihara M, Kitami K, Mogi K, et al
    Long-term post-recurrence survival outcomes in young women receiving fertility-sparing surgery for epithelial ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2021;267:221-225.
    PubMed     Abstract available


  30. LIANG X, Zeng H, Chen S, Jiang M, et al
    Ovarian metastasis risk factors in endometrial carcinoma: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2021;267:245-255.
    PubMed     Abstract available


  31. CHEN Y, Han L, Zheng A
    Association between statin use and the risk, prognosis of gynecologic cancer: A meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2021;268:74-81.
    PubMed     Abstract available


    October 2021
  32. OU YC, Fu HC, Lan J, Wu CH, et al
    The role of prolonged progestin treatment and factors predicting successful fertility-sparing treatment for early endometrial endometrioid adenocarcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2021;267:99-104.
    PubMed     Abstract available


  33. FRIEDRICH L, Meyer R, Levin G
    Management of adnexal mass: A comparison of five national guidelines.
    Eur J Obstet Gynecol Reprod Biol. 2021;265:80-89.
    PubMed     Abstract available


  34. KERSHAW V, Hickey I, Wyld L, Jha S, et al
    The impact of risk reducing bilateral salpingo-oophorectomy on sexual function in BRCA1/2 mutation carriers and women with Lynch syndrome: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2021;265:7-17.
    PubMed     Abstract available


  35. JEFFERY HE, Gillespie AM, Macdonald M
    Evaluation of women referred to the two-week wait gynaecology clinic with suspected ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2021;266:145-149.
    PubMed     Abstract available


    August 2021
  36. LIU G, Wang Y, Chen Y, Ren F, et al
    Malignant transformation of abdominal wall endometriosis: A systematic review of the epidemiology, diagnosis, treatment, and outcomes.
    Eur J Obstet Gynecol Reprod Biol. 2021;264:363-367.
    PubMed     Abstract available


    July 2021
  37. SHARMA JB, Kumar R, Singh U, Kumari A, et al
    Pre treatment and post treatment positron emission tomography-computed tomography (PET-CT) to evaluate treatment response in tuberculous Tubo-Ovarian masses.
    Eur J Obstet Gynecol Reprod Biol. 2021;264:128-134.
    PubMed     Abstract available


  38. KANNEGANTI A, Bhadiraju P, Tong PSY
    Extragonadal teratomas in women and adolescent girls: A systematic review.
    Eur J Obstet Gynecol Reprod Biol. 2021;262:134-141.
    PubMed     Abstract available


    June 2021
  39. NEF J, Huber DE
    Ovarian Sertoli-Leydig cell tumours: A systematic review of relapsed cases.
    Eur J Obstet Gynecol Reprod Biol. 2021;263:261-274.
    PubMed     Abstract available


    April 2021
  40. CHOU HH, Chen WC, Yang LY, Huang HJ, et al
    Postoperative adjuvant dose-dense chemotherapy with bevacizumab and maintenance bevacizumab after neoadjuvant chemotherapy for advanced ovarian cancer: A phase II AGOG/TGOG trial.
    Eur J Obstet Gynecol Reprod Biol. 2021;262:13-20.
    PubMed     Abstract available


  41. ATHEY RA, Macdonald MC, Jha S
    Stage of ovarian cancer at diagnosis. Does presentation as an emergency make a difference?
    Eur J Obstet Gynecol Reprod Biol. 2021;261:7-11.
    PubMed     Abstract available


    March 2021
  42. ALMAHDY AM, Elassall GM, Abdelbadee AY, Abd-Elkariem AY, et al
    Prognostic value of systematic lymphadenectomy in patients with ovarian cancer: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2021;267:179-185.
    PubMed     Abstract available


  43. GKROZOU F, Pappa C, Tsonis O, Dimitriou E, et al
    Relaxin as a potential diagnostic biomarker for ovarian cancer- A prospective study.
    Eur J Obstet Gynecol Reprod Biol. 2021;260:99-104.
    PubMed     Abstract available


    February 2021
  44. CAPMAS P, Suarthana E, Tulandi T
    Further evidence that endometriosis is related to tubal and ovarian cancers: A study of 271,444 inpatient women.
    Eur J Obstet Gynecol Reprod Biol. 2021;260:105-109.
    PubMed     Abstract available


    November 2020
  45. ZHANG JL, Li DF, Li DY, Ma LG, et al
    A rare malignant transformation of endometriosis.
    Eur J Obstet Gynecol Reprod Biol. 2020 Nov 27. pii: S0301-2115(20)30741.
    PubMed    


  46. BOURDEL N, Huchon C, Abdel Wahab C, Azais H, et al
    Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
    Eur J Obstet Gynecol Reprod Biol. 2020 Nov 20. pii: S0301-2115(20)30758.
    PubMed     Abstract available


  47. CARBONE MV, Cavaliere AF, Fedele C, Vidiri A, et al
    Uterine tumor resembling ovarian sex-cord tumor: Conservative surgery with successful delivery and case series.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:326-332.
    PubMed     Abstract available


  48. ZILLIOX M, Lecointre L, Azais H, Ballester M, et al
    Management of borderline ovarian tumours during pregnancy: Results of a French multi-centre study.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:412-418.
    PubMed     Abstract available


  49. VOUTSADAKIS IA
    A systematic review and meta-analysis of hormone receptor expression in low-grade serous ovarian carcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:172-178.
    PubMed     Abstract available


  50. TANG X, Zhang X, Liu X, Zheng T, et al
    A novel laparoscopy-based model for the prediction of optimal cytoreduction and prognosis of epithelial ovarian cancer in a Chinese population.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:256-262.
    PubMed     Abstract available


  51. FONNES T, Telle IO, Forsse D, Falck R, et al
    Cancer awareness in the general population varies with sex, age and media coverage: A population-based survey with focus on gynecologic cancers.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:25-31.
    PubMed     Abstract available


    October 2020
  52. KONSGEN D, Klinkmann G, Kaul A, Diesing K, et al
    Soluble heat-shock protein 27 in blood serum is a non-invasive prognostic biomarker for ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2020;255:154-159.
    PubMed     Abstract available


  53. KOLEHMAINEN AM, Pasanen AM, Koivisto-Korander RL, Butzow RC, et al
    Molecular characterization in the prediction of disease extent in endometrial carcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2020 Oct 16. pii: S0301-2115(20)30669.
    PubMed     Abstract available


  54. ZHAO J, Wu J, Zuo W, Kang S, et al
    A functional polymorphism in the poly(ADP-ribose) polymerase-1 gene is associated with platinum-based chemotherapeutic response and prognosis in epithelial ovarian cancer patients.
    Eur J Obstet Gynecol Reprod Biol. 2020;255:183-189.
    PubMed     Abstract available


  55. FERRARI F, Ficarelli S, Forte S, Valenti G, et al
    Extra-abdominal ovarian cancer presenting with breast metastases at diagnosis: Case report and literature review.
    Eur J Obstet Gynecol Reprod Biol. 2020;255:211-221.
    PubMed     Abstract available


    September 2020
  56. YOSHIHARA M, Tamauchi S, Iyoshi S, Kitami K, et al
    Does uterine preservation affect survival outcomes of patients with stage I ovarian sex cord-stromal cell tumours? A multi-institutional study.
    Eur J Obstet Gynecol Reprod Biol. 2020;254:52-56.
    PubMed     Abstract available


    August 2020
  57. CHEN S, Yang B, Fan J
    Diagnostic value of Anti-Mullerian hormone in ovarian granulosa cell tumor: A meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2020;253:266-272.
    PubMed     Abstract available


    July 2020
  58. KHIAT S, Provansal M, Bottin P, Saias-Magnan J, et al
    Fertility preservation after fertility-sparing surgery in women with borderline ovarian tumours.
    Eur J Obstet Gynecol Reprod Biol. 2020;253:65-70.
    PubMed     Abstract available


    March 2020
  59. CHEVROT A, Hequet D, Fauconnier A, Huchon C, et al
    Impact of surgical restaging on recurrence in patients with borderline ovarian tumors: A meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2020;248:227-232.
    PubMed     Abstract available


    January 2020
  60. RUDAITIS V, Mikliusas V, Januska G, Jukna P, et al
    The incidence of occult ovarian neoplasia and cancer in BRCA1/2 mutation carriers after the bilateral prophylactic salpingo-oophorectomy (PBSO): A single-center prospective study.
    Eur J Obstet Gynecol Reprod Biol. 2020;247:26-31.
    PubMed     Abstract available


  61. NASIOUDIS D, Mastroyannis SA, Haggerty AF, Giuntoli RL 2nd, et al
    Fertility preserving surgery for high-grade epithelial ovarian carcinoma confined to the ovary.
    Eur J Obstet Gynecol Reprod Biol. 2020;248:63-70.
    PubMed     Abstract available


    November 2019
  62. OTIFY M, Laios A, Elshamy T, D'Angelo A, et al
    A systematic review and meta-analysis of the use of ultrasound to diagnose borderline ovarian tumours.
    Eur J Obstet Gynecol Reprod Biol. 2019;244:120-127.
    PubMed     Abstract available


  63. TARANNUM A, Sheikh H, Appiah-Sakyi K, Lindow SW, et al
    The diagnostic use of magnetic resonance imaging for acute abdominal and pelvic pain in pregnancy.
    Eur J Obstet Gynecol Reprod Biol. 2019 Nov 22. pii: S0301-2115(19)30542.
    PubMed     Abstract available


  64. RETTENMAIER MA, Micha JP, Bohart R, Goldstein BH, et al
    A retrospective study comparing the efficacy of dose-dense chemotherapy, intraperitoneal chemotherapy and dose-dense chemotherapy with hyperthermic intraperitoneal chemotherapy in the treatment of advanced stage ovarian carcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2019;244:101-105.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.